Emily is an internal medicine physician and commenced her DPhil in October 2024 supported by a Medical Research Council Clinical Research Training Fellowship. Under the supervision of Prof. Richard Price, A/Prof. Robert Commons, Dr. James Watson, and A/Prof. Sarah Auburn, her DPhil will generate evidence to define the efficacy and safety of different treatment strategies for Plasmodium vivax  malaria.  

Emily completed her medical training at the Universities of Cambridge and Oxford and spent a year as a Herchel Smith Scholar at Harvard University where she studied Global Health. She has worked as a clinician in Oxford, Reading, and London, and spent a year as an International Fellow in Tropical Medicine at the Menzies School of Health Research in Darwin, Australia, in 2020-21. She co-ordinated a collaborative project through the WorldWide Antimalarial Resistance Network to define parasitaemia thresholds for diagnosing vivax malaria and conducted systematic reviews and meta-analyses on severe haemolysis during primaquine treatment for P. vivax. 

Qualifications